Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilastatin vs Thiosulfate for Nephroprotection in Ovarian Cancer HIPEC
NCT07229040Phase 2Recruiting
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Feb 2025
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilastatin in acute kidney injury (AKI), sponsored by Gregorio Marañón University General Hospital. Started Feb 2025; status: recruiting.
02
Drugs
cilastatin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07229040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229040.